Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × Erlotinib Hydrochloride × Clear all

NCT00039182 2013-01-24

Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural